JOSÉ LUIS
GONZÁLEZ LARRIBA
Catedrático de universidad
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (8)
2024
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Clinical and Translational Oncology
2023
-
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine, Vol. 389, Núm. 6, pp. 504-513
2022
2019
-
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132
2009
-
Screening for epidermal growth factor receptor mutations in lung cancer
New England Journal of Medicine, Vol. 361, Núm. 10, pp. 958-967
2007
-
Sorafenib TARGET trial results in Spanish patients
Clinical and Translational Oncology, Vol. 9, Núm. 10, pp. 671-673
2004
-
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer
Clinical Lung Cancer, Vol. 5, Núm. 6, pp. 360-365
2000
-
Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
European Journal of Cancer, Vol. 36, Núm. 18, pp. 2344-2352